OCSL vs OGN · P/E 20, $1.05B cap vs P/E 3.4, rev $3.02B
Oaktree Specialty Lending Corp (OCSL) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Oaktree Specialty Lending Corp (OCSL) is a asset management company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
OCSL does not have a complete income-statement cache yet.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
OCSL currently screens at market cap $1.05B and trailing P/E 20.2. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the OCSL and OGN stock pages for the full models.
Not investment advice.